merck kgaa - Search News

News

Merck KGaA to Buy US Drugmaker Springworks

Bloomberg on MSN · 15h

Merck KGaA’s $3.9 Billion Springworks Deal to Boost US Presence

Merck KGaA’s $3.9 billion deal to buy SpringWorks Therapeutics Inc. will expand the German conglomerate’s presence in the US at a time when many companies are seeking to increase investment in the country.

Reuters on MSN · 14h

Germany's Merck KGaA in $3.9 billion deal to buy US biotech firm SpringWorks

Germany's Merck KGaA has struck a deal to buy U.S. biotech company SpringWorks Therapeutics for an equity value of $3.9 billion to add rare cancer therapies ahead of expected revenue losses linked to expiring patents.

Yahoo Finance · 20h

Merck KGaA to buy biotech SpringWorks for $3.9B

The deal, which has been in the works for months, hands the German pharmaceutical company two approved drugs for rare tumors.

Fierce Pharma17h

Merck KGaA springs back into M&A game with $3.9B buyout of Pfizer spinout SpringWorks

Merck KGaA’s long courtship of SpringWorks Therapeutics has come to fruition as the German drugmaker has bought out the ...

Devdiscourse14h

Merck's Strategic $3.9 Billion Move: A Boon for Rare Cancer Therapies

Germany's Merck KGaA will acquire US biotech firm SpringWorks Therapeutics for $3.9 billion. This strategic move aims to ...

The Pharma Letter18h

Merck to acquire rare diseases company SpringWorks

After reported discussions since February, German pharma and sciences company Merck KGaA (MRK: DE) has confirmed its ...

17h

Temu, Tesla prices, Merck KGaA deal: Trending Tickers

Online retailer Temu — owned by PDD Holdings (PDD) — aims to raise prices amid tariffs, while Tesla (TSLA) raises its EV ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results